
Arbutus Biopharma Corp (ABUS) EPS is poised to hit -0.03 next quarter: How Investors Can Make It Count the Most?
As on Thursday, Arbutus Biopharma Corp (NASDAQ: ABUS) started slowly as it slid -3.79% to $4.32, before settling in for the price of $4.49 at